Fulltext

Kidney-synthesized erythropoietin is the main source for the hypoxia-induced increase in plasma erythropoietin in adult humans

Lundby, Anne-Kristine ; Keiser, Stefanie ; Siebenmann, Christoph ; Schäffer, Leonhard ; Lundby, Carsten

In: European Journal of Applied Physiology, 2014, vol. 114, no. 6, p. 1107-1111

Add to personal list
    Title
    • Kidney-synthesized erythropoietin is the main source for the hypoxia-induced increase in plasma erythropoietin in adult humans
    Author
    • Lundby, Anne-Kristine. Center for Integrative Human Physiology, Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland
    • Keiser, Stefanie. Center for Integrative Human Physiology, Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland
    • Siebenmann, Christoph. Center for Integrative Human Physiology, Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland
    • Schäffer, Leonhard. Department of Obstetrics, University Hospital Zürich, Zürich, Switzerland
    • Lundby, Carsten. Center for Integrative Human Physiology, Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057, Zürich, Switzerland
    Document Type
    • Postprint
    Language
    • English
    Published in
    • European Journal of Applied Physiology, 2014, vol. 114, no. 6, p. 1107-1111. Springer Berlin Heidelberg
    Other Version
    OAI-PMH Identifier
    • oai:doc.rero.ch:326228
    Summary
    Purpose: Erythropoietin (EPO) is mainly synthesized within renal peritubular fibroblasts, and also other tissues such as the liver possess the ability. However, to what extent non-kidney produced EPO contributes to the hypoxia-induced increase in circulating EPO in adult humans remains unclear. Methods: We aimed to quantify this by assessing the distribution of EPO glycoforms which are characterized by posttranslational glycosylation patterns specific to the synthesizing cell. The analysis was performed on samples obtained in seven healthy volunteers before, during and after 1month of sojourn at 3,454m altitude. Results: Umbilical cord (UC) plasma served as control. As expected a peak (p<0.05) in urine (2.3±0.5-fold) and plasma (3.3±0.5-fold) EPO was observed on day 1 of high-altitude exposure, and thereafter the concentration decreased for the urine sample obtained after 26days at altitude, but remained elevated (p<0.05) by 1.5±0.2-fold above the initial sea level value for the plasma sample. The EPO glycoform heterogeneity, in the urine samples collected at altitude, did not differ from values at sea level, but were markedly lower (p<0.05) than the mean percent migrated isoform (PMI) for the umbilical cord samples. Conclusion: Our studies demonstrate (1) UC samples express a different glycoform distribution as compared to adult humans and hence illustrates the ability to synthesis EPO in non-kidney cells during fetal development (2) as expected hypoxia augments circulating EPO in adults and the predominant source here for remains being kidney derived.